China established pilot carbon markets in 2013. In 2020, it set targets for carbon peaking in 2030 and carbon neutrality by 2050. China’s national carbon market officially commenced operations in 2021. Based on the national market and seven pilot markets, this study established the factors influencing carbon trading prices by examining market participants, macroeconomics, energy prices, carbon prices in other markets, etc. Asymmetrical development among the seven pilot cities, for which the study employed a mixed-effects model, was the primary factor impacting carbon prices. The carbon prices in the pilot cities cannot be extrapolated to the entire country. In the national carbon market, where the study employed a multiple regression lag model, the SSE index was positively correlated with carbon prices, whereas the Dow Jones index had no significant effect on carbon prices in terms of macroeconomics. Coal and natural gas prices were negatively correlated with carbon prices, whereas oil prices were positively correlated with energy prices. The EU market prices have a positive correlation with prices in other markets. The significance of this study is that it covers the largest national Emissions Trading System (ETS) in the world and allows for comparing the characteristics of the Chinese market with those of other ETS markets. Additional studies, including more sectors, should be conducted as China’s ETS coverage increases.

In a territorial development model such as that of Valencia (Spain), in which limitations, resistance and difficulties are observed as a result of the dualization that it has undergone in these almost 40 years of operation, we ask whether these obstacles have had an effect on the evolution of employment. This is understood as the basic indicator, the primary aim of any action undertaken for development of the territory. To this end, we set out from the methodological articulation of various techniques (survey by means of a pre-coded questionnaire, application of the READI® methodology) based on the primary information collected from the AEDL (Employment and Local Development Agents) technical staff of Valencia province, which showed us their perception of the dualization to which the model is subjected and the difficulties that this generates when carrying out their professional activity. Statistical and documentary sources were also analyzed. With all this, the evolution of employment in these territories over the last five years was studied in order to validate, or not, the initial hypothesis: Whether this reality of the model (duality) responds to short-term or structural parameters.

In the new era, an important component of China’s social governance system construction is to strengthen and innovate social governance to improve the ability and level of social governance in China. To ensure the long-term stability of the country and the well-being of the vast majority of the people, it is necessary to be adept at strengthening social governance, continuously improve and improve the governance system that is suitable for the development of modern society with scientific thinking methods, and enhance the level and capacity of governance in China. Based on this, this paper discusses how to promote the innovation of social governance in the digital age, and proposes innovative ideas on the model of social organization governance under the guidance of <Economic Diversification Plan for Macao SAR (2024–2028)>.

This review discusses the significant progress made in the development of CNT/GO-based biosensors for disease biomarker detection. It highlights the specific applications of CNT/GO-based biosensors in the detection of various disease biomarkers, including cancer, cardiovascular diseases, infectious diseases, and neurodegenerative disorders. The superior performance of these biosensors, such as their high sensitivity, low detection limits, and real-time monitoring capabilities, makes them highly promising for early disease diagnosis. Moreover, the challenges and future directions in the field of CNT/GO-based biosensors are discussed, focusing on the need for standardization, scalability, and commercialization of these biosensing platforms. In conclusion, CNT/GO-based biosensors have demonstrated immense potential in the field of disease biomarker detection, offering a promising approach towards early diagnosis. Continued research and development in this area hold great promise for advancing personalized medicine and improving patient outcomes.